Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: preliminary results of a phase II and pharmacogenomic study.

Source:http://linkedlifedata.com/resource/pubmed/id/15199530

Download in:

View as

General Info

PMID
15199530